LONDON, May 2 (Reuters) - Novo Nordisk posted on Thursday first-quarter operating profit above analyst forecasts, as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from Eli Lilly.

(Reporting by Maggie Fick Editing by Terje Solsvik)